{
    "accession": "ENCBS805RWS",
    "age": "36",
    "age_units": "year",
    "applied_modifications": [],
    "biosample_term_id": "EFO:0002793",
    "biosample_term_name": "HL-60",
    "biosample_type": "cell line",
    "characterizations": [],
    "dbxrefs": [],
    "description": "HL-60 derived M2A macrophages (72hr)",
    "documents": [
        {
            "attachment": "/documents/ae021ff9-4099-4701-957c-7effb7341962/@@download/attachment/Macrophage_differentiation_and_M1_M2_activation%20%281%29.pdf",
            "document_type": "differentiation protocol",
            "references": [],
            "urls": []
        }
    ],
    "donor": "ENCDO000AAM",
    "health_status": "acute promyelocytic leukemia",
    "lab": "Ali Mortazavi, UCI",
    "life_stage": "adult",
    "organism": "Homo sapiens",
    "references": [],
    "sex": "female",
    "source": "ATCC",
    "summary": "Homo sapiens HL-60 cell line treated with 10 \u03bcM phorbol 13-acetate 12-myristate for 120 hours, 10 ng/mL interleukin-13 for 72 hours, 10 ng/mL interleukin-4 for 72 hours",
    "treatments": [
        {
            "dbxrefs": [],
            "duration": 120,
            "duration_units": "hour",
            "treatment_term_id": "CHEBI:37537",
            "treatment_term_name": "phorbol 13-acetate 12-myristate",
            "treatment_type": "chemical"
        },
        {
            "dbxrefs": [],
            "duration": 72,
            "duration_units": "hour",
            "treatment_term_id": "UniProtKB:P35225",
            "treatment_term_name": "interleukin-13",
            "treatment_type": "protein"
        },
        {
            "dbxrefs": [],
            "duration": 72,
            "duration_units": "hour",
            "treatment_term_id": "UniProtKB:P05112",
            "treatment_term_name": "interleukin-4",
            "treatment_type": "protein"
        }
    ]
}